Lenalidomide in solid tumor patients with inflammatory cancer cachexia: A multicenter, randomized, double-blind, proof-of-concept study of fixed dose or CRP-response-guided dose or placebo.
F. Strasser
Research Funding - Celgene
R. Oberholzer
Research Funding - Celgene
D. Blum
Research Funding - Celgene
M. Joerger
Research Funding - Celgene
C. Driessen
Research Funding - Celgene
S. deWolf-Linder
Research Funding - Celgene
S. R. Haile
Research Funding - Celgene
R. von Moos
Research Funding - Celgene
N. Zerkiebel
Research Funding - Celgene
A. Jatoi
No relevant relationships to disclose
R. Woelky
No relevant relationships to disclose
K. Fearon
No relevant relationships to disclose
T. Cerny
Research Funding - Celgene